Pediatric Epilepsy Study

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
EpilepsyEpilepsies, Partial
Interventions
DRUG

oxcarbazepine

Trial Locations (30)

10016

New York

10032

New York

14222

Buffalo

19104

Philadelphia

19806

Wilmington

23507

Norfolk

24105

Kiel

30342

Atlanta

33155

Miami

33607

Tampa

35233

Birmingham

36693

Mobile

44106

Cleveland

44308

Akron

45229

Cincinnati

48109

Ann Arbor

55102

Saint Paul

55805

Duluth

63017

Chesterfields

76104

Fort Worth

77030

Houston

77694

Kehl-Kork

83712

Boise

90027

Los Angeles

90095

Los Angeles

92868

Orange

93638

Madera

97201

Portland

01401-901

Brigadeiro Hospital, Sao Paulo - SP

Unknown

Novartis, Mexico City

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY